Trump Order Threatens Supervised Consumption, Harm Reduction
Federal Funding Shifts: Harm Reduction vs. Abstinence Debate Intensifies
A recent executive order signals a important shift in federal drug policy, prioritizing abstinence and treatment over harm reduction services. This move has ignited a fierce debate within the drug policy world, questioning whether harm reduction efforts complement or undermine recovery initiatives.
The executive order specifically targets organizations that “fail to promote treatment, recovery, and self-sufficiency,” implying a directive to steer federal funding away from programs that offer housing and harm reduction without explicitly pushing participants toward abstinence. The Department of Health and Human Services (HHS) has stated that Secretary Robert F. Kennedy Jr. is “wholly aligned” with the order,emphasizing the need for “effective,common-sense solutions that keep people out of cyclic crisis and move them into a life of recovery.”
This stance has been welcomed by some advocates who believe harm reduction and ”housing first” policies have become to permissive. Tom Wolf, a San Francisco resident in recovery, expressed support for the reform, stating, “Trump basically said that the federal government is no longer going to allow people to camp out on the street and do drugs all day long.”
However, harm reduction proponents argue that their programs are vital for keeping individuals who use drugs alive and healthy, regardless of their immediate desire to stop. They point to data demonstrating the effectiveness of services like syringe exchange in preventing infectious disease transmission and evidence from supervised consumption sites worldwide that show a reduction in drug-related mortality.
Organizations like OnPoint emphasize that their services are accessible to all, and while recovery isn’t always the explicit initial goal, it often becomes the outcome. Many individuals initially engage with OnPoint for supervised consumption services, but subsequently utilize a wide range of offerings, including sterile supplies, laundry, mail services, meals, acupuncture, and eventually, case management and medical care, which can lead them to seek detox programs or medication for opioid use disorder.
In a related development, a federal court in Pennsylvania has allowed a Philadelphia nonprofit, Safehouse, to argue that its proposed supervised consumption site is protected under religious freedom. Safehouse has been seeking to open such a site since 2018, facing opposition from various levels of government. A three-judge panel of the 3rd Circuit Court of Appeals ruled that Safehouse can present its case,asserting that its Judeo-Christian values compel it to save lives and reduce harm. The Trump administration initially opposed Safehouse’s efforts, and the Biden administration continued the federal lawsuit. Safehouse stated, “The Court’s opinion recognizes what we have always believed: The law safeguards our mission to preserve human life in an unprecedented overdose crisis.”